252 results match your criteria: "Byramjee-Jeejeebhoy Government Medical College[Affiliation]"
J Clin Tuberc Other Mycobact Dis
February 2025
Weill Cornell Medicine, Center for Global Health, 402 East 67th Street, 2nd Floor, New York, NY 10065, USA.
Background: Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+ responses to TB antigens, during pregnancy and postpartum.
Methods: We screened 516 pregnant women for TB infection (TBI) with IGRA.
Cureus
January 2025
General Internal Medicine, Luton and Dunstable University Hospital, Luton, GBR.
Background Wound dehiscence (WD) is a major postoperative complication following abdominal surgeries, particularly exploratory laparotomy. Identifying preoperative risk factors and using predictive tools, such as the Rotterdam Risk Index (RRI), are crucial for early intervention and improving patient outcomes. This study aimed to evaluate the risk factors associated with WD and assess the predictive accuracy of the RRI in a cohort of patients undergoing abdominal surgeries.
View Article and Find Full Text PDFIndian Dermatol Online J
October 2024
Department of Dermatology, Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Background: Post-acne scarring causes severe physical and psychological distress. Multiple treatment modalities are available with no single gold standard treatment.
Aim And Objectives: To assess and compare the efficacy and safety of fractional CO2 laser and microneedling in atrophic acne scars and corelate with variables like scar type, duration, and Fitzpatrick skin types.
Emerg Microbes Infect
December 2025
Department of Virology and Biotechnology, National Institute for Research in Tuberculosis, Indian Council of Medical Research (ICMR), Chennai, India.
The identification of individuals with the greatest risk of progression to active tuberculosis (TB) disease from the huge reservoir of () infected individuals continues to remain an arduous ascent in the global effort to control TB. In a two-year prospective study, we analysed metabolic profiles in the unstimulated and TB antigen stimulated QuantiFERON supernatants of 14 healthy household contacts (HHCs) who progressed to TB disease (Progressors) and 14 HHCs who remained healthy (Non-Progressors). We identified 21 significantly dysregulated metabolites in the TB antigen-stimulated QuantiFERON supernatants of Progressors, of which the combination of Malic acid and N-Arachidonoylglycine had maximum AUC of 0.
View Article and Find Full Text PDFRheumatol Int
December 2024
Centre for Rheumatic Diseases, King's College London, London, UK.
Cureus
October 2024
Surgical Oncology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Objective This study aims to compare the efficacy of neoadjuvant methotrexate therapy followed by surgery versus primary surgical management in patients with stage III oral carcinoma. Methods Thirty patients diagnosed with stage III oral carcinoma were enrolled in this prospective study at a tertiary cancer research center. The patients were divided into two groups: 15 patients received neoadjuvant methotrexate therapy followed by surgery, while 15 underwent primary surgical management.
View Article and Find Full Text PDFCureus
September 2024
Nephrology, Ruby Hall Clinic, Pune, IND.
Cureus
September 2024
Internal Medicine, Byramjee Jeejeebhoy Government Medical College and Hospital, Pune, IND.
Indian J Plast Surg
August 2024
Institute of Craniofacial and Aesthetic Plastic Surgery, SIMS Hospital, Chennai, Tamil Nadu, India.
Rheumatology (Oxford)
September 2024
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
Int J Rheum Dis
September 2024
Division of Rheumatology and Clinical Immunology, Arthritis and Autoimmunity Center and UPMC Myositis Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Introduction: India's National TB Elimination Programme plans to roll out short-course TB preventive therapy (TPT) using 3 months of rifapentine and isoniazid (3HP). Understanding the feasibility and safety of children in programmatic settings is critical for widespread implementation. We present the findings of a targeted scale-up of 3HP among children and adolescents living with HIV (CALHIV) and child household contacts (>2 to <6 years) of pulmonary TB patients (CHHC).
View Article and Find Full Text PDFBackground: Following the emergence of the JN.1 SARS-CoV-2 variant, variants with key mutations in the spike protein, such as L455F, F456L, and R346T, were identified. In early January 2024, the KP.
View Article and Find Full Text PDFPLoS One
July 2024
Faculty of Medicine and Health Sciences, Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Stellenbosch University, Stellenbosch, South Africa.
Rifampicin-resistant (RR) tuberculosis (TB) in children is a major global health concern but is often neglected in economics research. Accurate cost estimations across the spectrum of paediatric RR-TB treatment regimens are critical inputs for prioritisation and budgeting decisions, and an existing knowledge gap at local and international levels. This normative cost analysis was nested in a Phase I/II pharmacokinetics, safety, tolerability, and acceptability trial of TB medications in children in South Africa, the Philippines and India.
View Article and Find Full Text PDFJ Travel Med
July 2024
National Collection of Industrial Microorganisms (NCIM), Biochemical Sciences Division, CSIR-National Chemical Laboratory (NCL), Pune 411008, Maharashtra, India.
Rheumatol Int
September 2024
Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Clin Infect Dis
October 2024
Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
In this prospective cohort of 2006 individuals with drug-susceptible tuberculosis in India, 18% had unfavorable treatment outcomes (4.7% treatment failure, 2.5% recurrent infection, 4.
View Article and Find Full Text PDFLancet Microbe
October 2024
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Tuberculosis is a leading cause of death from an infectious agent globally. Infectious subclinical tuberculosis accounts for almost half of all tuberculosis cases in national tuberculosis prevalence surveys, and possibly contributes to transmission and might be associated with morbidity. Modelling studies suggest that new tuberculosis vaccines could have substantial health and economic effects, partly based on the assumptions made regarding subclinical tuberculosis.
View Article and Find Full Text PDFJ Infect Dis
May 2024
Department of Biomedical Informatics, Harvard Medical School, Boston MA, USA.
Background: Transmission is contributing to the slow decline of tuberculosis (TB) incidence globally. Drivers of TB transmission in India, the country estimated to carry a quarter of the World's burden, are not well studied. We conducted a genomic epidemiology study to compare epidemiological success, host factors and drug resistance (DR) among the four major Mycobacterium tuberculosis (Mtb) lineages (L1-4) circulating in Pune, India.
View Article and Find Full Text PDFInt J Rheum Dis
May 2024
Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester, UK.
Int J Rheum Dis
May 2024
Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Background: The pandemic presented unique challenges for individuals with autoimmune and rheumatic diseases (AIRDs) due to their underlying condition, the effects of immunosuppressive treatments, and increased vaccine hesitancy.
Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study, a series of ongoing, patient self-reported surveys were conceived with the vision of being a unique tool to gather patient perspectives on AIRDs. It involved a multinational, multicenter collaborative effort amidst a global lockdown.
Clin Infect Dis
July 2024
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Cureus
March 2024
Infectious Diseases, Indian Council of Medical Research, National Institute of Virology, Pune, IND.
Background: In August 2023, the BA.2.86 SARS-CoV-2 variant, with over 30 spike protein mutations, emerged amidst the global dominance of XBB sub-lineages.
View Article and Find Full Text PDFJ Int AIDS Soc
April 2024
University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.
Introduction: Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low- and middle-income countries (LMICs), there is limited information about the burden of metabolic disorders on liver disease in PLHIV.
Methods: We conducted a cross-sectional analysis of baseline data collected between October 2020 and July 2022 from the IeDEA-Sentinel Research Network, a prospective cohort enrolling PLHIV ≥40 years on antiretroviral treatment (ART) for ≥6 months from eight clinics in Asia, Americas, and central, East, southern and West Africa.